Hextar Healthcare Berhad (7803.KL)
- Previous Close
0.1200 - Open
0.1250 - Bid 0.1200 x --
- Ask 0.1250 x --
- Day's Range
0.1250 - 0.1250 - 52 Week Range
0.1150 - 0.2900 - Volume
10,000 - Avg. Volume
1,147,496 - Market Cap (intraday)
149.244M - Beta (5Y Monthly) 0.36
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date May 27, 2025 - Jun 6, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Jan 2, 2020
- 1y Target Est
--
Hextar Healthcare Berhad, an investment holding company, produces, sells, and exports household gloves, industrial gloves, and nitrile disposable gloves in Europe, Asia, North and South America, and internationally. It operates through Gloves Operation, Medical Devices Operation, and Investment Holding segments. The company offers latex, neoprene, and two tone gloves. It also manufactures and trades in in-vitro diagnostics rapid test kits and enzyme-linked immunosorbent assay test kits for detection and diagnoses of infectious diseases and drug-of-abuse screening for medical professionals and the clinical diagnostic markets. In addition, the company is involved in the trading of gloves, household and kitchen items, and personal protective products. Hextar Healthcare Berhad was founded in 1987 and is headquartered in Ipoh, Malaysia.
hextarhealthcare.com646
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 7803.KL
View MorePerformance Overview: 7803.KL
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is FTSE Bursa Malaysia KLCI (^KLSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 7803.KL
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 7803.KL
View MoreValuation Measures
Market Cap
132.25M
Enterprise Value
126.76M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.85
Price/Book (mrq)
0.26
Enterprise Value/Revenue
0.86
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-9.30%
Return on Assets (ttm)
-2.23%
Return on Equity (ttm)
-2.65%
Revenue (ttm)
149.7M
Net Income Avi to Common (ttm)
-13.92M
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
9.22M
Total Debt/Equity (mrq)
0.73%
Levered Free Cash Flow (ttm)
9.69M